Two specific microRNAs in the therapeutic vesicles block two key inflammatory pathways in brain immune cells by attaching to their genetic instructions and preventing the production of harmful...
Claim Context
The microRNA molecules miR-30e-3p and miR-181a-5p, carried by hiPSC-NSC-EVs, directly inhibit the NLRP3 inflammasome and cGAS-STING pathway, respectively, by binding to their target mRNAs and reducing downstream inflammatory protein production.
“miRNA-30e-3p and miRNA-181a-5p, both present in hiPSC-NSC-EVs, can significantly inhibit the activation of the NLRP3 inflammasome and the STING pathway, respectively.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether miR-30e-3p and miR-181a-5p are consistently identified as key regulators of NLRP3 and STING in extracellular vesicles across multiple stem cell sources and aging models.
A systematic review and meta-analysis of all studies profiling miRNA cargo in neural stem cell-derived EVs and testing their effects on NLRP3 and STING pathways, pooling data on miRNA abundance, target binding, and functional inhibition across cell types and species.
That intranasal delivery of purified miR-30e-3p and miR-181a-5p mimics replicates the anti-inflammatory and cognitive benefits of whole hiPSC-NSC-EVs in aged mice.
A double-blind RCT in 100 aged C57BL/6 mice (20 months) randomized to intranasal delivery of: 1) hiPSC-NSC-EVs, 2) synthetic miR-30e-3p + miR-181a-5p mimics, 3) scrambled miRNA controls, or 4) vehicle, with primary endpoints: hippocampal NLRP3/STING protein levels and NORT discrimination index at 7 days.
Whether endogenous levels of miR-30e-3p and miR-181a-5p in aged mouse brain correlate inversely with NLRP3 and STING activation over time.
A longitudinal cohort study measuring hippocampal miR-30e-3p and miR-181a-5p levels via qPCR in 50 aged mice at 18, 20, and 22 months, correlating these with concurrent NLRP3, ASC, p-STING, and IFN-α protein levels and cognitive performance.
Whether aged mice with the highest NLRP3 activation have the lowest levels of miR-30e-3p and miR-181a-5p in hippocampal EVs compared to low-inflammation mice.
A case-control study comparing 25 aged mice with high hippocampal NLRP3 activation (NLRP3 > mean + 1 SD) to 25 with low activation (NLRP3 < mean - 1 SD), measuring miR-30e-3p and miR-181a-5p levels in isolated hippocampal EVs via RT-qPCR.
Whether there is a statistical association between miR-30e-3p concentration and NLRP3 protein levels in hippocampal EVs from aged mice at a single time point.
A cross-sectional analysis of 40 aged mice measuring miR-30e-3p and miR-181a-5p levels in hippocampal EVs via RT-qPCR and correlating them with NLRP3 and STING protein levels measured by ELISA in the same samples.